Welcome to our February newsletter from the wild, wet and windswept British Isles. Things are getting back to normal over here now and I’d just like to inform you that Drug Discovery Today completely escaped all ill effects of the recent Winter storms.In this issue, we will be discussing cell-specific delivery of biologicals, challenges in their pre-clinical safety testing and the use of mass spectrometry in biopharmaceutical drug discovery.The free downloads available in this newsletter highlight some of the most recent developments in biotherapeutic drug discovery and development. I will elaborate on them below.
25 February, 2014